The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Comparison of long-term cardiac effects of 9- and 52-week trastuzumab in HER2-positive early breast cancer.
Mehmet Ali Nahit Sendur
No relevant relationships to disclose
Sercan Aksoy
No relevant relationships to disclose
Nuriye Ă–zdemir
No relevant relationships to disclose
Hikmet Yorgun
No relevant relationships to disclose
Fatma Meric Yilmaz
No relevant relationships to disclose
Ozan Yazici
No relevant relationships to disclose
Cevdet Zungun
No relevant relationships to disclose
Kudret Aytemir
No relevant relationships to disclose
Kadri Altundag
No relevant relationships to disclose
Nurullah Zengin
No relevant relationships to disclose